Prof. Jaak Järv

He is graduated in 1972 from the Chemistry Department of Tartu State University . The post-graduate course in 1973 – 1976 was followed by the defence of the candidate’s degree in chemistry at the Institute of Chemistry of the Estonian Academy of Sciences. The topic of the candidate’s thesis was “Investigation of the specificity and reaction mechanism of acetylcholinesterase using chemical kinetics methods and quantitative structure activity dependences”.
He defended his doctorate in chemistry in 1990 at the University of Moscow with work, the importance of which was the introduction of chemical kinetics methods to elucidate receptor ligand action mechanisms. He was elected as professor in 1991.
After postgraduate studies, he worked as a senior scientist in the same department from 1976, in 1982-1983 he was an associate professor, 1983-1991 deputy vice-rector for research, 1985-1991 scientific supervisor of the laboratory of bio-organic chemistry, 1998-2003 dean of the Faculty of Physics and Chemistry. Since 1991, he has been a professor at the University of Tartu.
In 2008, he was elected a member of the Estonian Academy of Sciences in the field of natural sciences. He belongs to the Academy’s Department of Biology, Geology and Chemistry. Since 2007, he has been the chairman of the publishing board of the Estonian Academy of Sciences and the editor-in-chief of the Proceedings of the Estonian Academy of Sciences (since 1997). Since 2014, he has been a member of the board of the Estonian Academy of Sciences and since 2017 the secretary general. He is the representative of the Estonian Academy of Sciences in the Council of EASAC (Research Council of European Academies).
He is a member of the European Neurochemical Society (1988), American Chemical Society (1997, Royal Society of Biochemistry (2000), Academia Europaea (2020) and Estonian Biochemical Society (president 2004–2011) and Vice-President of the Estonian Chemical Society (2016– ).

His current research is focused on design and synthesis of PET ligands, mostly used in CNS studies, and investigation into the molecular mechanism of interaction of these compounds with their target sites.